Detalles de la búsqueda
1.
A phase I study evaluating the pharmacokinetics, safety and tolerability of an antibody-based tissue factor antagonist in subjects with acute lung injury or acute respiratory distress syndrome.
BMC Pulm Med
; 12: 5, 2012 Feb 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-22340260
2.
Phase I trial of ALT-801, an interleukin-2/T-cell receptor fusion protein targeting p53 (aa264-272)/HLA-A*0201 complex, in patients with advanced malignancies.
Clin Cancer Res
; 17(24): 7765-75, 2011 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21994418
Resultados
1 -
2
de 2
1
Próxima >
>>